Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Companion Animal Arthritis Market

Companion Animal Arthritis Market Share

Report ID: GMI10785
Published Date: Aug 2024
Report Format: PDF

Download Free Sample

Companion Animal Arthritis Market Share

The companion animal arthritis industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products based on different technologies is among a key market strategy. Some of the leading industry players have a notable presence in the market.

Companion Animal Arthritis Market Companies

Prominent players operating in the companion animal arthritis industry are as mentioned below:

American Regent, Inc.
Bayer AG (Bayer Animal Health)
Boehringer Ingelheim International GmbH
CEVA Santé Animale
Dechra Pharmaceuticals plc
Elanco Animal Health Incorporated
Eltech K-Laser s.r.l.
Medivet
Norbook Laboratories Ltd.
Nutramax Laboratories Veterinary Sciences, Inc
Vetoquinol SA
Vibrac
Zoetis, Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global companion animal arthritis market was valued at around USD 3.4 billion in 2023 and will register a 7.2% CAGR, driven largely by rising pet ownership, and higher incidence rate of arthritis among dogs and cats.

The medication segment was worth USD 1.5 billion in 2023, owing to its role in symptom management, in consort with advancements in veterinary medicine, such as better diagnostics, stronger medications, and comprehensive treatment protocols.

In 2023, North America captured a 45.6% share of the global companion animal arthritis market, with anticipated strong growth driven by increasing pet ownership, greater awareness of animal health, and advancements in veterinary care.

American Regent, Inc., Bayer AG (Bayer Animal Health), Boehringer Ingelheim International GmbH, CEVA Sant